KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,700,073 | -6.8% | 3,256,587 | +8.1% | 0.00% | 0.0% |
| Q2 2023 | $31,879,106 | -32.2% | 3,013,148 | -21.6% | 0.00% | -33.3% |
| Q1 2023 | $46,995,952 | -57.4% | 3,842,678 | -56.8% | 0.00% | 0.0% |
| Q4 2022 | $110,360,318 | +84.9% | 8,892,854 | +103.6% | 0.00% | -25.0% |
| Q3 2022 | $59,677,000 | +7.4% | 4,368,763 | +44.1% | 0.00% | +33.3% |
| Q2 2022 | $55,569,000 | +4.7% | 3,031,614 | -8.2% | 0.00% | 0.0% |
| Q1 2022 | $53,076,000 | +12.2% | 3,300,748 | -2.3% | 0.00% | +50.0% |
| Q4 2021 | $47,294,000 | -21.3% | 3,378,143 | +5.3% | 0.00% | -33.3% |
| Q3 2021 | $60,107,000 | -11.4% | 3,209,109 | -1.4% | 0.00% | -25.0% |
| Q2 2021 | $67,859,000 | -15.3% | 3,254,642 | +14.9% | 0.00% | -20.0% |
| Q1 2021 | $80,107,000 | -8.4% | 2,833,650 | +5.8% | 0.01% | 0.0% |
| Q4 2020 | $87,438,000 | +64.8% | 2,677,220 | +54.6% | 0.01% | +25.0% |
| Q3 2020 | $53,044,000 | +96.8% | 1,731,199 | +4.7% | 0.00% | +100.0% |
| Q2 2020 | $26,955,000 | +150.0% | 1,653,701 | +52.6% | 0.00% | +100.0% |
| Q1 2020 | $10,783,000 | -26.0% | 1,083,727 | +2.2% | 0.00% | 0.0% |
| Q4 2019 | $14,579,000 | -21.6% | 1,060,283 | -13.6% | 0.00% | 0.0% |
| Q3 2019 | $18,606,000 | +17.1% | 1,226,528 | +52.0% | 0.00% | 0.0% |
| Q2 2019 | $15,889,000 | +1.5% | 806,946 | -14.5% | 0.00% | 0.0% |
| Q1 2019 | $15,658,000 | +27.7% | 943,837 | +8.0% | 0.00% | 0.0% |
| Q4 2018 | $12,266,000 | -40.1% | 873,626 | -25.4% | 0.00% | -50.0% |
| Q3 2018 | $20,484,000 | +8.7% | 1,170,346 | +13.1% | 0.00% | 0.0% |
| Q2 2018 | $18,840,000 | +29.0% | 1,035,181 | +32.9% | 0.00% | +100.0% |
| Q1 2018 | $14,603,000 | +231.1% | 778,884 | +170.3% | 0.00% | – |
| Q4 2017 | $4,411,000 | +22.1% | 288,126 | +19.1% | 0.00% | – |
| Q3 2017 | $3,612,000 | +159.1% | 241,878 | +61.5% | 0.00% | – |
| Q2 2017 | $1,394,000 | – | 149,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |